Behind Trump’s 100% Tariffs: China’s New Drugs That Cannot Be Contained
Apr 02,2026
US Imposes Tariffs, China Seeks Premiums
China’s Innovative Drugs Going Global: From “Annual Boom” to “Quarterly Surge”
Apr 01,2026
Q1 2026 Panorama Review: China Innovative Drug BD
Wall Street Capital Targets China’s Biotech Sector
Mar 31,2026
Renowned VC Firm RA Capital Launches a SPAC
Mar 30,2026
An Irreversible Wave
Mar 29,2026
On Perseverance, Transformation, and Expectation
Mar 29,2026
Legend Capital, Rxilient, and TONACEA are jointly hosting a special session themed "Global Development of Pharmaceutical Enterprises and Emerging Market Collaboration." The session will focus on the latest policies, market opportunities and challenges, product and industry go-to-market strategies, and localization practices in Southeast Asia, the Middle East and North Africa, and Latin America.